Heartflow, Inc. - Common Stock (NQ:HTFL)

59.01 +2.00 (+3.51%)

Delayed Quote Updated: 12:45 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Heartflow, Inc. - Common Stock

< Previous 1 2 Next >

HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High ↗

September 15, 2026

The provider of an artificial intelligence-powered cardiac diagnostic platform reported a notable insider stock sale.

Via The Motley Fool

Topics Regulatory Compliance

HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High ↗

September 06, 2026

The medical technology company reported a notable insider sale as its shares delivered a 59% one-year return.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors? ↗

August 20, 2026

The medical technology company reported a notable insider sale as shares returned 35% over the past year.

Via The Motley Fool

Topics Regulatory Compliance

Heartflow Inc (NASDAQ:HTFL) Beats Q1 Estimates and Hikes Full-Year Outlook, But Stock Slips After Hours ↗

May 14, 2026

Via Chartmill

Heartflow Inc (NASDAQ:HTFL) Reports Strong Q4 Revenue Beat and Improved Margins Despite After-Hours Share Decline ↗

March 18, 2026

Via Chartmill

Why Heartflow Stock Soared Today ↗

August 14, 2026

The healthcare technology leader is using artificial intelligence to detect coronary artery disease early.

Via The Motley Fool

Topics Artificial Intelligence

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

August 14, 2026

Via Chartmill

Friday's session: gap up and gap down stocks ↗

August 14, 2026

Via Chartmill

Discover the top movers in Friday's pre-market session. ↗

August 14, 2026

Via Chartmill

Heartflow Q2 Earnings Call Highlights ↗

August 13, 2026

Heartflow (NASDAQ:HTFL) reported second-quarter revenue of $64.1 million, up 48% from a year earlier, as growth in its Plaque Analysis offering, durable FFR-CT utilization and continued expansion of...

Via MarketBeat

Topics Earnings

HeartFlow Q2 2026 Earnings Call Transcript ↗

August 13, 2026

HeartFlow (NASDAQ:HTFL) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For...

Via Benzinga

Topics Earnings

Stay updated with the stocks that are on the move in today's after-hours session. ↗

August 13, 2026

Via Chartmill

What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors? ↗

July 15, 2026

The medical technology company reported a notable insider sale in recent filings.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? ↗

July 08, 2026

Heartflow boasts rapid AI-driven growth but faces reimbursement headwinds, while Omeros bets everything on its first commercial launch.

Via The Motley Fool

Topics Artificial Intelligence

Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 04, 2026

Heartflow scales AI diagnostics while Iovance drives personalized cancer therapies, each faces unique financial and operational risks in 2026.

Via The Motley Fool

Topics Artificial Intelligence

HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026? ↗

June 24, 2026

AI-powered diagnostics meet global oncology innovation as two medical disruptors post strong revenue growth, yet face distinct risk and valuation profiles.

Via The Motley Fool

Topics Artificial Intelligence

These stocks are moving in today's after hours session ↗

June 19, 2026

Via Chartmill

Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? ↗

May 31, 2026

HeartFlow delivers AI-powered, non-invasive cardiac diagnostics for hospitals and cardiology clinics using proprietary imaging technology.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Heartflow Q1 Earnings Call Highlights ↗

May 14, 2026

Heartflow (NASDAQ:HTFL) reported a sharply higher first-quarter revenue total and raised its full-year 2026 outlook, citing strength in its core FFRCT business, faster-than-expected adoption of its...

Via MarketBeat

Topics Artificial Intelligence Earnings

Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Money ↗

May 12, 2026

Heartflow and Neptune Insurance deserve a closer look.

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering

Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors. ↗

May 08, 2026

HeartFlow provides AI-driven tools for non-invasive heart diagnostics, serving hospitals and clinics with advanced cardiovascular insights.

Via The Motley Fool

Topics Artificial Intelligence

What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale ↗

March 25, 2026

HeartFlow delivers AI-powered cardiac diagnostics to hospitals worldwide; a key insider recently trimmed their stake, SEC filings show.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares? ↗

March 22, 2026

HeartFlow delivers AI-powered, non-invasive cardiac diagnostics to healthcare providers seeking advanced imaging and decision support tools.

Via The Motley Fool

EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes ↗

February 04, 2026

CEO Brent Ness noted a broad global market, with approximately 266 million people affected by chronic low back pain.

Via Stocktwits

Topics Artificial Intelligence

Is Recent IPO Stock Heartflow a Buy After a Director Scooped Up Shares Worth Over $1 Million? ↗

December 28, 2025

AI-powered cardiac diagnostics firm HeartFlow reported a recent insider buy, as disclosed in the latest SEC filing.

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering Regulatory Compliance

Why AI Stock HeartFlow Triumphed on Thursday ↗

December 18, 2025

A key FDA-cleared analysis tool earned professional accolades for its utility.

Via The Motley Fool

Topics Artificial Intelligence

This Family Office Acquired $148 Million of Karman Stock as Shares Tripled Since February IPO ↗

November 30, 2025

One family office fund just made Karman its biggest reported equity bet—here’s what long-term investors should take from the move.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO ↗

November 30, 2025

A billionaire family office has made a big bet on a newly public AI-driven heart diagnostics company—here’s what long-term investors should take from the move.

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering Regulatory Compliance

Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million ↗

November 20, 2025

Bain Capital added more than 12.4 million shares of HeartFlow stock in the thrid quarter

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer ↗

November 20, 2025

Bain Capital's bet on Cidara Therapeutics stocks has paid off in a big way

Via The Motley Fool

Topics Regulatory Compliance

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.